Pr ecis: These findings show that DNA damage in mitochrondria promotes breast cancer progression and metastasis, offering a preclinical rationale to promote DNA repair in this organelle. 
Pr ecis: A rapid, noninvasive, and quantitative detection method for 2-hydroxyglutarate in human glioblastomas can distinguish IDH1 and IDH2 mutations in vivo, with implications for improving diagnosis and therapeutic monitoring of this disease.
MICROENVIRONMENT AND IMMUNOLOGY 50

Radiotherapy Combined with Novel STINGTargeting Oligonucleotides Results in Regression of Established Tumors
Jason R. Baird, David Friedman, Benjamin Cottam, Thomas W. Dubensky, Jr., David B. Kanne, Shelly Bambina, Keith Bahjat, Marka R. Crittenden, and Michael J. Gough Pr ecis: These exciting findings offer a preclinical rationale to immediately investigate in clinic the powerful properties of a novel ligand of STING-one of the most provocative immunotherapeutic targets at present-in enhancing the efficacy of neoadjuvant or adjuvant radiotherapy for human cancers. 
ABOUT THE COVER
Cyclic dinucleotides injected into tumors result in rapid hemorrhagic necrosis by activating the sensor STING. To examine expression of STING in the tumor environment, Panc02 pancreatic adenocarcinoma tumors grown in immune competent mice were stained for the macrophage marker F4/80 (red), STING (green), and the DAPI nuclear counterstain (blue). Both the cancer cells and the tumor stroma, including F4/80 þ tumor macrophages, expressed STING; however, in STING À/À mice, cyclic dinucleotides had no effect, indicating that it is the stromal rather than cancer expression of STING that mediates this effect. For details, see article by Baird and colleagues on page 50.
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